Serum Uric Acid/Creatinine Ratio as a Potential Biomarker for Non-alcoholic Fatty Liver Disease in Type 2 Diabetes
Background: One of the predominant diseases among patients suffering from Type 2 diabetes mellitus (T2DM) is non-alcoholic fatty liver disease (NAFLD). Finding reliable biomarkers for predicting NAFLD severity is required for early intervention and prevention of further diseases such as fibrosis, hepatocellular cancer,...